Blood disorders: future trends in iron chelation.
The treatment of iron overload in thalassaemic patients has for some time involved long periods of subcutaneous drug therapy. The inconvenience of sporting a portable syringe driver for up to ten hours at a time has led to reduced patient compliance rates, particularly among adolescent and teenage groups. Dorothy Jordan and George Kontoghiorghes describe a recent breakthrough which could result in many patients being able to resort to oral iron chelation therapy.